The COVID-19 Response Mechanism (C19RM) will stay open for new donor contributions until the end of September 2022. C19RM funds can be awarded until the end of March 2023, and the implementation period continues until 31 December 2023. When funding is available, eligible applicants can request C19RM funding through the funding request materials found below.
C19RM Application Materials
The resources below are designed to support applicants to prepare their C19RM funding requests.
- COVID-19 Response Mechanism (C19RM) - Funding Request Instructions
download in English | Español | Français - COVID-19 Response Mechanism (C19RM) - Funding Request Form
download in English | Español | Français - COVID-19 Response Mechanism (C19RM) – Funding Request Screening Checklist
download in English | Español | Français - C19RM 2021 Unfunded Demand for Portfolio Optimization
download in multiple languages
Supporting Attachments
- C19RM Health Product Management Template
download in English | Español | Français - Health Product Management Template User Guidelines
download in English | Español | Français - C19RM Funding Landscape Table
download in English | Español | Français - C19RM 2021: Procurement Progress Reporting Template
download in English | Español | Français - Checklist to Support Completion and Submission of the C19RM Procurement Progress Reporting Template
download in English
Full and Fast-track Funding Requests
Implementing countries who wish to apply for C19RM funding can consult with their Global Fund Country Teams when further donor funding becomes available. Available types of funding requests include:
- Full Funding Requests: These enable countries to submit an ambitious funding request for prioritized programmatic needs, for an amount including both the designated C19RM Base Allocation and indicated C19RM Above Base Allocation. Since all countries may receive some C19RM Above Base Allocation funding, an ambitious request is strongly encouraged.
- Fast-track Funding Requests: These enable countries to expedite fulfilment of urgent procurement requirements, which includes PPE, diagnostics and therapeutics (including oxygen) and the costs relating to the effective deployment of these health products. Countries can submit up to half of their overall C19RM Base Allocation request through this optional approach.
Important
Applications must be endorsed by all Country Coordinating Mechanism members. In addition, COVID-19 control and containment interventions must be endorsed by the national COVID-19 response coordinating body.